Oryzon Genomics SA
|Category:||Clinical Stage Development Company Presentation|
|Speaker:||Carlos Buesa Arjol|
Oryzon is a public clinical company developing epigenetic therapies with a focus on personalized medicine in CNS disorders and Oncology. Oryzon team is composed by +50 highly qualified professionals located in Barcelona, Boston, NYC and San Diego. We have multiple shots on goal with two clinical Phase II stage compounds, in oncology and in CNS. Currently launching Phase II trials with registrational potential.